In sum, our experiments show that the correlation between high NSMCE2 expression levels in breast tumors and cancer patients’ poor response to chemotherapy is due, in part, to increased resistance to chemotherapeutic drugs driven by NSMCE2. The gene discussed is NSMCE2; the disease is breast neoplasm.